Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer

By WebmasterApril 3, 2018November 1st, 2024No Comments

Dr. Ottavio Vitolo Joins Relmada Therapeutics as Senior Vice President, Head of R&D and Chief Medical Officer

Previous PostCombination of Checkpoint Inhibitors and Intezyne's Novel Cancer Resistance Pathway Inhibitor IT-139 Shows Enhanced Immune Efficacy
Next PostIView Therapeutics was awarded SBIR Innovative grant by NIH's National Institute of Allergy and Infectious Diseases (NIAID)